BioNTech SE: BioNTech to Present New Clinical and Preclinical Data Across Multiple Immuno-Oncology Programs at 36th SITC Annual Meeting
MAINZ, Germany, October 1, 2021(Nasdaq: BNTX, "BioNTech" or "the Company"), a next generation immunotherapy company pioneering novel therapies for cancer and infectious diseases, today announced that new
Sylke Maas Melissal Johnson Fosun Pharma Sarah Cannon Cancer Institute Bayer Animal Health Tristar Centennial Medical Center
Source: finanznachrichten.de